Antidepressant Drugs Market Set to Surge to $21 Billion by 2030 at a 3% CAGR

The global antidepressant drugs market has witnessed significant growth over the past decade, reflecting the increasing prevalence of depressive disorders worldwide. As of 2020, the antidepressant drugs market was valued at approximately $15.65 billion and is projected to reach $21.00 billion by 2030, registering a CAGR of 3.0% from 2021 to 2030.

Read More Here: https://www.alliedmarketresearch.com/antidepressants-drugs-market

Antidepressant Drugs Market Segmentation
The antidepressant drugs market is segmented based on product type and depressive disorder.
1. By Product Type:
◦ Selective Serotonin Reuptake Inhibitors (SSRIs): This segment dominated the market in 2020 and is expected to continue its lead during the forecast period. The dominance is attributed to advancements in R&D activities in the healthcare sector and an increase in the prevalence of major depressive disorder and anxiety disorders.

◦ Serotonin Norepinephrine Reuptake Inhibitors (SNRIs): This segment is expected to witness considerable growth during the forecast period, owing to an increase in the prevalence of chronic neuropathic pain and obsessive-compulsive disorder (OCD).
◦ Tricyclic Antidepressants (TCAs)
◦ Monoamine Oxidase Inhibitors (MAOIs)
◦ Serotonin Antagonist and Reuptake Inhibitors (SARIs)
◦ Others

2. By Depressive Disorder:
◦ Major Depressive Disorder (MDD): This segment was the major contributor in 2020 and is expected to maintain its lead during the forecast period, owing to an increase in the prevalence of major depressive disorder and initiatives taken by governments and private organizations about the development of drugs.

◦ Obsessive-Compulsive Disorder (OCD): This segment is expected to witness considerable growth during the forecast period, owing to an increase in the prevalence of mental disorders and an increase in the number of approvals for anxiety drugs.
◦ Generalized Anxiety Disorder (GAD)
◦ Panic Disorder
◦ Others

Get Sample PDF Copy: https://www.alliedmarketresearch.com/request-sample/2593

Antidepressant Drugs Market Growth Factors
Several factors contribute to the growth of the antidepressant drugs market:

• Increasing Prevalence of Depression: Depression affects thoughts, behavior, feelings, and sense of well-being of a person and is caused due to biological, genetics, environment, and psychological factors. Low mood and aversion to physical activity are some of the common symptoms of depression. Depression is more common in women than men. Depression drugs work by fixing chemical imbalance such as lack of serotonin in the brain. Antidepressants help in treatment of depression by maintaining balance of various hormones and chemicals in the brain.

• Advancements in R&D Activities: Continuous research and development in the pharmaceutical sector have led to the introduction of novel antidepressant drugs with improved efficacy and safety profiles. For instance, in May 2020, the Food and Drug Administration (FDA) announced the approval of Tauvid, which is an antidepressant drug used for the treatment of patients with Alzheimer's disease.

• Rise in Geriatric Population: The increasing geriatric population is highly vulnerable to depression diseases, owing to social isolation and loneliness, which boosts demand for various antidepressant drug therapies for better health outcomes. According to the Journal of The National Academic of Science, in 2020, it was reported that around one-third of adults above the age of 65 years felt lonely and one-fourth of adults above 65 years are socially isolated. In addition, according to the Journal of National Institute on Aging, in February 2022, it was reported that loneliness and social isolation are associated with higher rates of depression.

• Increase in Awareness Regarding Mental Health: Growing awareness campaigns and initiatives by governments and non-profit organizations have led to increased recognition and diagnosis of depressive disorders, thereby driving the demand for antidepressant drugs.

Regional Insights
North America garnered a major share in the antidepressant drugs market in 2020 and is expected to continue to dominate during the forecast period. This is attributed to the rise in the prevalence of depression disorders, an increase in the number of approvals for antidepressant drugs, the presence of key players, and developments in R&D activities in the healthcare sector in the region.

However, the Asia-Pacific region is expected to register the highest CAGR of 4.9% from 2021 to 2030. This growth is due to an increase in the prevalence of mental disorders, a rise in awareness regarding depression, growth in healthcare expenditures, and an increase in the number of clinical trials.

Key Players in the Antidepressant Drugs Market
The global antidepressant drugs market is highly competitive, with several key players contributing to its growth. Some of the major companies operating in the market include:
• Alkermes Plc
• AbbVie Inc.
• Eli Lilly and Company
• GlaxoSmithKline, Inc.
• H. Lundbeck A/S
• Merck KGAA
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd. (Actavis Generics)
• Takeda Pharmaceutical Limited Company

These companies are focusing on strategic initiatives such as mergers and acquisitions, collaborations, and new product launches to strengthen their market position and expand their product portfolios.

The antidepressant drugs market is poised for steady growth in the coming years, driven by factors such as the increasing prevalence of depressive disorders, advancements in pharmaceutical research, and rising awareness about mental health.

Procure Complete Report: https://www.alliedmarketresearch.com/checkout-final/cbe167d5b6e587cc774dce90fbecc383

Thanks for reading this article; you can also get an individual chapter-wise sections or region-wise report versions like North America, LATAM, Europe, or Southeast Asia.

Contact Us:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.